Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 213 | 312 | 884 | 2,444 | -958 |
| Cost of Goods | 2,187 | 157 | 136 | 1,614 | 692 |
| Gross Profit | -1,974 | 155 | 748 | 830 | -1,650 |
| Operating Expenses | 2,326 | 3,036 | 3,955 | 5,570 | 3,211 |
| Operating Income | -4,113 | -2,724 | -3,071 | -4,126 | -4,169 |
| Interest Expense | 388 | 453 | 628 | 464 | 206 |
| Other Income | 248 | 449 | 171 | 1,601 | 4,711 |
| Pre-tax Income | -4,253 | -2,728 | -3,528 | -2,989 | 336 |
| Income Tax | -1 | 1 | 1 | N/A | 7 |
| Net Income Continuous | -3,100 | -2,729 | -4,681 | -2,989 | 1,761 |
| Net Income Discontinuous | -2,254 | 7,926 | N/A | N/A | -1,766 |
| Minority Interests | -44 | 1,323 | -219 | -402 | -432 |
| Net Income | $-5,310 | $3,874 | $-4,462 | $-2,587 | $427 |
| EPS Basic Total Ops | -0.53 | 0.44 | -0.62 | -0.38 | 0.24 |
| EPS Basic Continuous Ops | -0.31 | -0.31 | -0.65 | -0.44 | 0.49 |
| EPS Basic Discontinuous Ops | -0.19 | 0.91 | N/A | N/A | -0.31 |
| EPS Diluted Total Ops | -0.53 | 0.44 | -0.62 | -0.38 | 0.24 |
| EPS Diluted Continuous Ops | -0.31 | -0.31 | -0.65 | -0.44 | 0.49 |
| EPS Diluted Discontinuous Ops | -0.19 | 0.91 | N/A | N/A | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.61 | -0.31 | -0.62 | -0.38 | 0.06 |
| EBITDA(a) | $-3,516 | $-2,110 | $-2,720 | $-3,221 | $-3,394 |